Leucine enkephalin(Virpax Pharmaceuticals)

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameLeucine enkephalin(Virpax Pharmaceuticals)
Drug Alias NamePES-200NES-100NM-0127NM-127
ClassificationBiologics
Mechanisms of Actionδ-opioid receptor agonists
Targetsδ-opioid receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticCancer PainPain +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirpax Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Advancing Translational Sciences
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-TraumaticCancer PainPain +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A